The Venture Codex Logo

The Venture Codex

Pivotal bioVenture Partners China

Suite 1203-04, Tower 2, Century Link, No.1196 Century Avenue, Pudong District, Shanghai, 200122, China

Overview

Investment firm focused on biotechnology ventures.

Founded

2018

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Seed
Series A
Series B

Geographic focus

China
United States

Sector focus

Financial Services

Investment portfolio

6rounds
NAMEDATESIZE
Heranova Lifesciences
Jan 2024Participated
$14 MSeed
Ablaze Pharmaceuticals
Nov 2021Participated
$75 MSeries A
Arctic Vision
Mar 2021Participated
$100 MSeries B
Visen Pharmaceuticals
Jan 2021Participated
$150 MSeries B
OncXerna Therapeutics
Jun 2019Led
$80 MSeries B
OncXerna Therapeutics
Jun 2018Led
$17 MSeed
Heranova Lifesciences
Jan 2024Participated
$14 MSeed
Ablaze Pharmaceuticals
Nov 2021Participated
$75 MSeries A
Arctic Vision
Mar 2021Participated
$100 MSeries B
Visen Pharmaceuticals
Jan 2021Participated
$150 MSeries B
OncXerna Therapeutics
Jun 2019Led
$80 MSeries B
OncXerna Therapeutics
Jun 2018Led
$17 MSeed
6
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Pivotal bioVenture Partners China: 6 funding rounds are recorded in the selected participation categories.All available history.
Pivotal bioVenture Partners China: 6 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11
Series A01
Series B12

Monthly Deal Activity

Pivotal bioVenture Partners China: 6 deals are recorded across 101 months.All available history.
Pivotal bioVenture Partners China: 6 deals are recorded across 101 months. All available history
MonthDeals
Jun '181
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '191
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '211
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '211
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '241
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Pivotal bioVenture Partners China: Health & Life Sciences is the largest displayed sector by deal count (6 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Pivotal bioVenture Partners China: Health & Life Sciences is the largest displayed sector by deal count (6 deals). All available history
SectorDeals
Health & Life Sciences6

Deal Size Distribution

Pivotal bioVenture Partners China: 6 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Pivotal bioVenture Partners China: 6 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M0
$50M-$100M2
$100M-$250M2
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Pivotal bioVenture Partners China: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Pivotal bioVenture Partners China: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
China3
Pivotal bioVenture Partners China: 20 co-investors are shown, with Nan Fung Life Sciences sharing 4 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Pivotal bioVenture Partners China: 20 co-investors are shown, with Nan Fung Life Sciences sharing 4 recorded deals. All available history
Co-investorShared deals
Nan Fung Life Sciences4
Vivo Capital2
Advantech Capital1
Ascendis Pharma1
CDG Capital1
CMB International1
Cormorant Asset Management1
Emerging Technology Partners1
HBM Healthcare Investments1
Hongshan Capital Group (Sequoia Capital China)1
Korea Investment Partners1
Logos Capital1
Loyal Valley Capital1
Morningside Ventures1
Octagon Capital1
OrbiMed1
Panacea Venture1
RAYZ Investments1
Samsara BioCapital1
Sherpa Healthcare Partners1

Investment Strategy

Pivotal bioVenture Partners China: Led accounts for 33% and participating for 67% of round participation.All available history.
Pivotal bioVenture Partners China: Led accounts for 33% and participating for 67% of round participation. All available history
CategoryDeals (count)Share (%)
Led233%
Participating467%
Pivotal bioVenture Partners China: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Pivotal bioVenture Partners China: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Vincent Cheung

Founder & Managing Partner